A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Midostaurin 13C6 - Request Quote

Picture of Midostaurin 13C6

Midostaurin 13C6

SZ CAT No:SZ-M063D01
CAS No
NA
Mol.F.
C2913C6H30N4O4
Mol.Wt.
576.6
Inv. Status
Synthesis on demand
Rel. CAS No120685-11-2 (Unlabeled)

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Midostaurin 13C6 is chemically N-((5S,6R,7R,9R)-6-methoxy-5-methyl-14-oxo-6,7,8,9,15,16-hexahydro-5H,14H-17-oxa-4b,9a,15-triaza-5,9-methanodibenzo[b,h]cyclonona[jkl]cyclopenta[e]-as-indacen-7-yl)-N-methylbenzamide-1,2,3,4,5,6-13C6. Midostaurin 13C6 is supplied with detailed characterization data compliant with regulatory guideline. Midostaurin 13C6 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Midostaurin.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Midostaurin 13C6

Purchase Midostaurin 13C6

Midostaurin 13C6 suppliers

Midostaurin 13C6 manufacturers

Midostaurin 13C6 price

Order Midostaurin 13C6

Enquire Midostaurin 13C6

Midostaurin 13C6 cost

Midostaurin 13C6 Supplier

Midostaurin 13C6 Distributor

Midostaurin 13C6 for Method Validation

Midostaurin Reference Standard

Midostaurin 13C6 for ANDA Filing

Midostaurin 13C6 for Forced Degradation Studies

Midostaurin 13C6 Identification Standards

Midostaurin 13C6 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,